Schedule 13D ownership disclosure
JASPER THERAPEUTICS INC
Voting Common Stock, par value $0.0001 per share · CUSIP: 471871202
Event date: 2026-02-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- The Carlyle Group Inc.Reported CIK 0001527166
Shares: 1,088,310.00 · Class: 3.8%
- Carlyle Holdings I GP Inc.Reported CIK 0001548626
Shares: 1,088,310.00 · Class: 3.8%
- Carlyle Holdings I GP Sub L.L.C.Reported CIK 0001548627
Shares: 1,088,310.00 · Class: 3.8%
- Carlyle Holdings I L.P.Reported CIK 0001548628
Shares: 1,088,310.00 · Class: 3.8%
- CG Subsidiary Holdings L.L.C.Reported CIK 0001790577
Shares: 1,088,310.00 · Class: 3.8%
- TC Group, L.L.C.Reported CIK 0000933790
Shares: 1,088,310.00 · Class: 3.8%
- Carlyle Investment Management L.L.C.Reported CIK 0001354120
Shares: 1,088,310.00 · Class: 3.8%
- Carlyle Genesis UK LLCReported CIK 0001941860
Shares: 1,088,310.00 · Class: 3.8%
- Abingworth LLPReported CIK 0001397144
Shares: 1,088,310.00 · Class: 3.8%
- Abingworth Bioventures VII LPReported CIK 0001688313
Shares: 1,088,310.00 · Class: 3.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-007366
- Form type
- SCHEDULE 13D/A
- Filer
- Carlyle Group Inc.
- CIK
- CIK 1527166
- Filed
- Feb 18, 2026
- Reporting period
- Feb 18, 2026
- Description
- Schedule 13D beneficial ownership